Bridgeway Capital Management, LLC Neuronetics, Inc. Transaction History

Bridgeway Capital Management, LLC

$4.76 Billion
Q1 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 83,005 shares of STIM stock, worth $145,258. This represents 0.01% of its overall portfolio holdings.

Number of Shares

83,005

Previous 63,005 31.74%

Holding current value

$145,258

Previous $182,000 117.03%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $53,600 - $96,000	20,000 Added 31.74%	83,005 $395,000
Q4 2023 Feb 14, 2024	SELL	$1.05 - $2.9 $26,250 - $72,500	-25,000 Reduced 28.41%	63,005 $182,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $2.22 $32,250 - $55,500	25,000 Added 39.68%	88,005 $118,000
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $165,600 - $233,600	-80,000 Reduced 55.94%	63,005 $135,000
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $61,676 - $147,277	21,949 Added 18.13%	143,005 $416,000

Q4 2022 Feb 14, 2023	SELL	$3.44 - $6.87 $154,456 - $308,463	-44,900 Reduced 27.06%	121,056 $831,000
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.66 $206,684 - $409,851	87,951 Added 112.75%	165,956 $528,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $52,250 - $92,750	-25,000 Reduced 24.27%	78,005 $250,000
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $213,210 - $339,334	-75,074 Reduced 42.16%	103,005 $312,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $580,786 - $988,987	150,074 Added 535.88%	178,079 $794,000
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $1.5 Million - $3.74 Million	-240,900 Reduced 89.59%	28,005 $184,000
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $146,210 - $248,486	14,405 Added 5.66%	268,905 $4.31 Million
Q1 2021 May 17, 2021	SELL	$10.6 - $21.27 $199,280 - $399,876	-18,800 Reduced 6.88%	254,500 $3.15 Million
Q4 2020 Feb 16, 2021	BUY	$4.95 - $11.45 $717,255 - $1.66 Million	144,900 Added 112.85%	273,300 $3.04 Million
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $232,596 - $750,186	-127,800 Reduced 49.88%	128,400 $624,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.61 $219,396 - $406,116	155,600 Added 154.67%	256,200 $494,000
Q1 2020 May 15, 2020	SELL	$1.28 - $4.5 $31,872 - $112,050	-24,900 Reduced 19.84%	100,600 $190,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $141,856 - $324,544	35,200 Added 38.98%	125,500 $564,000
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $750,393 - $1.18 Million	90,300 New	90,300 $750,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Neuronetics, Inc. Transaction History